Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARVN · against 454 other Healthcare companies listed in US-listed
Ranked #158 of 455 · scores higher than 64% of peers
Bars: peers in each 10-point band of the growth score52 peers with a growth score of 70–79, including ARVN · Click a bar to see the companies
Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | ARVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | -15.0% | 11.0% | 13% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 26.1% | 11.0% | 74% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 152 | 1.5B USD | 79 | 43 | |
| 152 | 374M USD | 79 | 66 | |
| 152 | 646M USD | 79 | 46 | |
| 158 | 1.8B USD | 78 | 63 | |
| 158 | 457M USD | 78 | 58 | |
| 158 | 8.7B USD | 78 | 26 | |
| 158 | 31.3B USD | 78 | 63 | |
| 158 | 126.5B USD | 78 | 56 | |
| 158 | 1.1B USD | 78 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score